Characterization of IL36, a novel cytokine

新型细胞因子 IL36 的表征

• 批准号: 8174696
• 负责人: Albert Zlotnik
• 金额: $ 22.24万
• 依托单位: UNIVERSITY OF CALIFORNIA-IRVINE
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-05-15 至 2013-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8174696
• 关键词: Affect; Amino Acids; Antibodies; Antibody Formation; Antigen Presentation; Antigen-Presenting Cells; Antigens; Archives; Atopic Dermatitis; B-Lymphocytes; Bioinformatics; Biological; Biological Assay; CD3 Antigens; CD4 Positive T Lymphocytes; CD8B1 gene; Cell Maturation; Cells; Characteristics; Cytokine Gene; Databases; Delayed Hypersensitivity; Dendritic Cells; Development; Disease; Epithelial Cells; Exhibits; Formalin; Freezing; Gene Expression; Genes; Human; Human Genome; Human body; Hybridomas; Immune; Immune response; Immune system; In Vitro; Inflammation; Inflammatory Response; Interleukins; Knockout Mice; Leukocytes; Mature T-Lymphocyte; Measures; Molecular Weight; Mucous Membrane; Mus; Organ; Paraffin Embedding; Pathogenesis; Patients; Peptide Signal Sequences; Peritoneal Macrophages; Phenotype; Population; Process; Production; Proteins; Psoriasis; Recombinants; Regulation; Role; Sampling; Screening procedure; Skin; Skin Tissue; Source; T cell differentiation; T-Cell Activation; T-Cell Receptor; T-Lymphocyte; T-Lymphocyte Subsets; Testing; Therapeutic; Time; Tissue Sample; Tissues; Vitiligo; base; cytokine; embryonic stem cell; genome-wide; human disease; human tissue; immune function; in vivo; indexing; macrophage; melanoma; monocyte; novel; overexpression; peripheral blood; polyclonal antibody; research study; skin disorder; thymocyte

DESCRIPTION (provided by applicant): We have constructed a comprehensive database of gene expression with more than 90 human tissues and cells, which we call a Body Index of Gene Expression (BIGE), based on the genome-wide Affymetrix 133 2.0 gene array. Given that many human genes remain uncharacterized, we sought to identify novel genes associated with the immune system through a systematic analysis of the BIGE database. We identified many genes that exhibit strong expression in T, B cells, monocytes, or dendritic cells, including 92 uncharacterized genes that encode either transmembrane or secreted proteins. Following extensive bioinformatics analyses of these genes, we identified a novel secreted protein expressed by activated macrophages and dendritic cells. We have tentatively called this protein Interleukin 36. IL36 is a small protein of 311 amino acids and exhibits a signal peptide of 45 amino acids, predicting a mature protein of 266 amino acids, with an estimated molecular weight of ~29KDa. It is expressed in human peripheral blood monocytes or mouse peritoneal macrophages following activation with LPS. Interestingly, it is also expressed in human or mouse immature dendritic cells, but is downregulated upon maturation of these cells. CD4 T cells also produce it upon activation with anti CD3. Besides leukocytes, IL36 is also expressed in mucosal tissues, and in the skin, suggesting that epithelial cells also express it. Since several antigen presenting cells express IL36, we hypothesize that IL36 affects T cell activation and may also influence their differentiation. We have expressed recombinant mouse and human IL36, and produced polyclonal antibodies. In Specific Aim 1, we will search for biological activities of IL36 on T cells in vitro. We will test IL36 on proliferation and differentiation assays on thymocytes, or mature T cells. We will also use T cell hybridomas and antigen-primed T cells to study possible effects of IL36 on T cell activation, and on the ability of macrophages and dendritic cells to present antigen. We will also study the regulation of IL36 expression by CD4 T cells, macrophages and dendritic cells. In Specific Aim 2, we will produce an IL36 knockout mouse. To this end, we already have ES cells where the IL36 gene has been inactivated. We will characterize the phenotype of the IL36 (-/-) mouse by analyzing the cells of its immune organs and by measuring various immune functions. In Specific Aim 3, we will study the possible role of IL36 in human skin diseases, by studying its expression in archived skin samples from patients with various diseases. We will also study its expression in normal skin and mucosal tissues. These experiments will help us characterize IL36 and its role in immune responses and inflammation. PUBLIC HEALTH RELEVANCE: Through a systematic screening of a comprehensive human database of gene expression we identified a novel cytokine which we called IL36. In this proposal, we aim to undertake its biological characterization, by exploring its effects on leukocytes in vitro as well as its function in vivo.

描述（由申请人提供）：我们已经构建了一个具有90多种人类组织和细胞的基因表达的综合数据库，我们称之为基因表达的身体指数（BIGE），该数据库基于全基因组的Affytelvis 133 2.0基因阵列。鉴于许多人类基因仍然没有特征，我们试图通过对BIGE数据库的系统分析来识别与免疫系统相关的新基因。我们鉴定了许多在T、B细胞、单核细胞或树突细胞中表现出强表达的基因，包括92个编码跨膜或分泌蛋白的未表征基因。在对这些基因进行广泛的生物信息学分析后，我们鉴定了一种由活化的巨噬细胞和树突状细胞表达的新型分泌蛋白。我们暂时将这种蛋白质称为白细胞介素36。IL 36是一个由311个氨基酸组成的小分子蛋白，具有45个氨基酸的信号肽，预测其为266个氨基酸的成熟蛋白，估计分子量约为29 KDa。在LPS激活后，在人外周血单核细胞或小鼠腹腔巨噬细胞中表达。有趣的是，它也在人或小鼠未成熟树突状细胞中表达，但在这些细胞成熟后下调。CD 4 T细胞在抗CD 3活化后也产生它。除了白细胞，IL 36也在粘膜组织和皮肤中表达，这表明上皮细胞也表达IL 36。由于几种抗原呈递细胞表达IL 36，我们假设IL 36影响T细胞活化，也可能影响它们的分化。我们已经表达了重组小鼠和人IL 36，并产生了多克隆抗体。在具体目标1中，我们将在体外研究IL 36对T细胞的生物学活性。我们将在胸腺细胞或成熟T细胞的增殖和分化测定中测试IL 36。我们还将使用T细胞杂交瘤和抗原致敏的T细胞来研究IL 36对T细胞活化以及对巨噬细胞和树突状细胞呈递抗原的能力的可能影响。我们还将研究CD 4 T细胞、巨噬细胞和树突状细胞对IL 36表达的调节。在特定目标2中，我们将产生IL 36敲除小鼠。为此，我们已经有了IL 36基因失活的ES细胞。我们将通过分析其免疫器官的细胞和通过测量各种免疫功能来表征IL 36（-/-）小鼠的表型。在具体目标3中，我们将通过研究IL 36在各种疾病患者的存档皮肤样本中的表达来研究IL 36在人类皮肤疾病中的可能作用。我们还将研究其在正常皮肤和粘膜组织中的表达。这些实验将帮助我们表征IL 36及其在免疫反应和炎症中的作用。 公共卫生相关性：通过系统筛选人类基因表达的综合数据库，我们鉴定了一种新的细胞因子，我们称之为IL 36。在这个建议中，我们的目标是进行其生物学特性，通过探索其在体外白细胞的影响，以及其在体内的功能。